Articles On Cann Group (ASX:CAN)

ASX cannabis shares faded from the spotlight in 2020 as the coronavirus pandemic took over. But the Australian medical marijuana companies have been working through COVID-19 disruptions as they look to scale their businesses. Some have bee...

ASX companies continued to raise money in July, with over $4bn shelled out by investors, taking 2020’s total above $30bn. According to Bloomberg, there has been $32.3bn worth of cash raised between January 1 and August 3. This is well ahead...

Cannabis shares were considered a fad for a while. Now, they’ve proved they’re here to stay. As the Australian medicinal cannabis industry grows, ASX cannabis companies are refining their strategies. While some are focused on cultivation a...

A quick wrap of the ASX’s key winners and losers on Thursday, July 23. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. Today 798 stocks rose, 500 de...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

The S&P/ASX 200 Index (ASX: XJO) has run out of steam on Wednesday and is dropping lower. In late morning trade the benchmark index is down a sizeable 0.9% to 6,099.5 points. Four shares that have fallen more than most today are listed...

Summary Medicinal cannabis manufacturer Cann Group announced capital raising via SPP and Placement with the issue price at a 51.2% discount to 14 July closing price. The Group has not secured funding for construction of Mildura facility...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) has given back its early gains and is heading lower. At the time of writing the benchmark index is down 0.1% to 6,006.1 points. Four shares that have fallen more than most today ar...

The Cann Group Ltd (ASX: CAN) share price has tanked this morning after the cannabis grower announced a $24.3 million capital raising at a steep discount to yesterday’s closing price. Shares were trading down 16% at the open in response to...

One of Australia's leading cannabis companies is issuing new shares at a 51.2 per cent discount to raise $24.3 million for working capital. Cann Group, which was the nation's first to receive medicinal cannabis production and research lic...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Medicinal cannabis cultivator Cann Group was fronting funds on Wednesday morning, with a deal that its biggest shareholder was passing on. 

The Althea Group Holdings Ltd (ASX: AGH) share price is on the rise today. This follows an announcement that company’s subsidiary has entered into a cannabis beverage production agreement. Althea’s subsidiary, Peak Processing Solutions, ha...

ASX cannabis shares have staged a mixed recovery since March. The Althea Group Holdings Ltd (ASX: AGH) and Cann Group Ltd (ASX: CAN) shares have had strong comebacks but the Auscann Group Holdings Ltd (ASX: AC8) price has been softer. Coro...

S&P Dow Jones Indices has announced the quarterly rebalance of the entire S&P/ASX index hierarchy, revealing which companies have been added and removed. This review of the ASX’s major indices – the S&P/ASX 20, 50, 100, 200, 300...

Here’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small cap health stocks and of those which were trading on Tuesday, 66 were in positive territory over the last fortnight, 18 were flat and 47 saw t...

Australian cannabis developer Cann Group (ASX: CAN) has signed two agreements for the supply of medicinal cannabis-formulated oil and dried flower products to markets in the United Kingdom and European Union. The first deal is with UK-based...

26 May 2020 - The Cann Group (ASX:CAN) has executed two new export supply agreements with European and UK partners for the supply of a range of medicinal cannabis formulated oil an…

The S&P/ASX 200 Index (ASX: XJO) is on course to record another strong gain on Tuesday. In late morning trade the benchmark index is up 1.4% to 5,695.1 points. Four shares that are climbing more than most today are listed below. Here’s...

North American pot stocks are roaring back from lows in March but the same cannot be said for their antipodean counterparts, many of which continue to wallow. The New Cannabis Ventures Global Cannabis Stock Index soared 26 per cent last wee...

Queensland medical marijuana group THC Global (ASX:THC) has started selling its products in Australia, with the first one available by prescription under the government’s Special Access Scheme (SAS). THC is one of several companies which an...

ASX cannabis shares have faced a difficult few months. Struck by a capital crunch earlier this year, cannabis shares were then hammered in the March downturn. Last year wasn’t much better, with the vaping crisis and slow roll out of Canada...

ASX cannabis shares are staging a comeback after the depths of the March bear market. Auscann Group Holdings Ltd (ASX: AC8) shares are up over 15% this morning, and 57% from March lows. AusCann has now commenced clinical evaluation of its...

ASX cannabis shares have proven to be susceptible to coronavirus, with valuations slashed in the recent market downturn. This is the second crisis to hit cannabis shares in the past year, after the “vape crisis” in late 2019.  The current...

The Althea Group Holdings Ltd (ASX: AGH) share price has fallen materially over the last few weeks following the coronavirus-induced market volatility. In fact, it isn’t just Althea which has been impacted. The likes of Auscann Group Holdi...

The THC Global Group Ltd (ASX: THC) share price has returned from its trading halt and is zooming higher on Tuesday morning. At the time of writing the cannabis company’s shares are up 11% to 34.5 cents. Why was the THC Global share price...

Reporting season wrapped up last week with the S&P/ASX 200 Index (INDEXASX: XJO) falling more than 10% from recent highs. As fears around the spread of coronavirus escalated, the contagion of fear infected markets, prompting a major c...

The Cann Group Ltd (ASX: CAN) share price has plunged 5.15% in early trade after the cannabis cultivator released its half year results last night. Cann Group reported a loss for the half year, but is seeking to transition to near-term pro...

The breakdown in the corporate North American marijuana sector is having ramifications in the Australian industry, and it’s unclear how big an impact the ructions will continue to have. Lower than expected take up of recreational marijuana...

In afternoon trade the S&P/ASX 200 index is on course to end the week in the red. At the time of writing the benchmark index is down 0.6% to 7,009.1 points. Four shares that are falling more than most today are listed below. Here’s why...

Cann Group (CAN) has successfully completed the issue of convertible notes to raise just under $8 million A total of 8 million shares were issued to six sophisticated and professional investors at the price of $1 per share Of this, Cann...

The Cann Group Ltd (ASX: CAN) share price is trading lower on Friday after raising funds for working capital requirements. In morning trade the cannabis company’s shares are down 3% to $1.27. What did Cann Group announce? This morning Cann...

Following a 30 per cent gain in 2019, the S&P/ASX Emerging Companies index – which measures overall performance of the ASX microcap sector — moved another 3 per cent higher in January. Of the sub-$400m market cap companies on our list,...

The Cann Group Ltd (ASX: CAN) share price was amongst the best performers on the All Ordinaries on Wednesday. The cannabis company’s shares climbed over 4% to $1.46. This stretched its year to date gain to an incredible 132%. Why did the C...

Medicinal cannabis company Cann Group (CAN) has changed its business strategy following recent demand and supply disruptions The company will focus on product sales into the Australian domestic market while export opportunities continue t...

Medicinal cannabis company Cann Group (CAN) has changed its business strategy following recent demand and supply disruptions The company will focus on product sales into the Australian domestic market while export opportunities continue t...

Cann Group (ASX:CAN) is pulling back from its original ambitious Mildura cannabis growing warehouse, saying a global oversupply has led it to change plans. Furthermore, major shareholder Aurora says it won’t participate in any new funding r...

ASX cannabis shares endured a tough 2019, as investors cooled on the latest investing trend. However, some of the biggest listed groups have bounced back in January and are up as much as 100% this year. Here’s why 3 of the biggest names in...

The All Ordinaries index has started 2020 in an exceptionally positive fashion. The year may be just a touch over four weeks old, but the index has already carved out a gain of 5.8%. Whilst this is impressive, a number of shares on the ind...

In afternoon trade the S&P/ASX 200 index is on course to record a disappointing decline. At the time of writing the benchmark index is down 0.75% to 7,079.2 points. Four shares that have not let that hold them back are listed below. He...

Shares in Cann Group Ltd (ASX: CAN) rose to fresh highs for the year yesterday. The Cann Group share price rose 22.55% during the day to close at $1.68, up significantly from Friday’s close of $1.36. The Cann Group share price has since f...

The S&P/ASX 200 index has followed the lead of U.S. markets and pushed higher on Monday. In afternoon trade the benchmark index is up 0.35% to 7,088.3 points. Four shares that are climbing more than most today are listed below. Here’s...

Only one prescription for medical marijuana has been issued by a doctor in the Northern Territory, according to Minister for Health Natasha Fyles. In a submission to the Senate inquiry into barriers to patient access to marijuana, Fyles sai...

In afternoon trade the S&P/ASX 200 index is on course to record another solid gain. At the time of writing the benchmark index is up 0.3% to 6,983.8 points. Four shares that have failed to follow the market higher today are listed belo...

The Cann Group Ltd (ASX: CAN) share price was on form again on Monday and recorded another strong gain. The medicinal cannabis company’s shares raced 13% higher to end the day at $1.07. This latest gain means that Cann Group’s shares have...

In afternoon trade the S&P/ASX 200 index has followed the lead of U.S. markets and is on course to record a strong gain. At the time of writing the benchmark index is up 1% to 6,884.1 points. Four shares that have failed to follow the...

As the world learns tasty cannabis edibles might not be the safest of munchies, Australian investors have served up 19 small cap cannabis stocks as gainers on the ASX. Cannabis edibles are legal in some US states and Canada and just one pro...

The S&P/ASX 200 index is back on form on Tuesday and storming higher this afternoon. At the time of writing the benchmark index is up 1.1% to 6,808.6 points. Not all shares have been able to follow the market higher today. Here’s why t...

Cann Group (CAN) and IDT Australia (IDT) have announced that GMP extraction activities are underway for the first batches of medicinal cannabis resin The extracted resin will be used as an active pharmaceutical ingredient to produce GMP me...

Cann Group (ASX: CAN) and IDT Australia (ASX: IDT) are closer to producing their first medicinal cannabis products with GMP extraction activities now underway. Once extracted, the resin will be used as an active pharmaceutical ingredient fo...